Try our Advanced Search for more refined results
November 19, 2020
AOP Orphan Pharmaceuticals AG v. Pharmaessentia Corporation
Case Number:
1:20-cv-12066
Court:
Nature of Suit:
Judge:
Firms
Companies
Sectors & Industries:
View recent docket activity
Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.
Coverage
-
March 11, 2022
AOP Orphan Wants Remnants Of €142M Award OK'd In Mass.
Although a German court ruled to set aside a €142 million ($161.8 million) arbitral award issued to Austrian pharmaceutical company AOP Orphan last month, the Austrian company and the Taiwanese drug developer who would have had to pay it have differing opinions on where their Massachusetts federal court dispute should go from here.
Parties
Stay ahead of the curve
In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.
- Direct access to case information and documents.
- All significant new filings across U.S. federal district courts, updated hourly on business days.
- Full-text searches on all patent complaints in federal courts.
- No-fee downloads of the complaints and so much more!
TRY LAW360 FREE FOR SEVEN DAYS
Already a subscriber? Click here to login